A Scholarly Sting Operation Shines a Light on ‘Predatory’ Journals

By |2021-11-11T17:14:06-08:00March 23rd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The New York Times today reported that researchers writing for the journal, Nature, found that There are now thousands of fake open-access journals, about as many as legitimate ones. The authors created a fake 'Editor" that they then applied to numerous 'scientific journals.' The applicant’s nom de plume was not [...]

Smoking Cessation Drug May Boost Cognition in Schizophrenia

By |2021-11-11T17:14:20-08:00March 22nd, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]

Powerful New Chinese Opioid Intensifies Crisis: Carfentanil linked to at least 700 deaths

By |2021-11-11T17:14:28-08:00February 18th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Carfentanil, an opioid said to be 100 times more powerful than fentanyl, has been tied to at least 700 deaths in numerous states. Worst hit include Michigan, Florida, and Ohio, according to data compiled by US authorities. Carfentanil was originally intended to sedate large animals, such as elephants, and is [...]

OPINION: Recent Study Critical of Psychotropic Prescribing in the Elderly May Belie Real World Treatment

By |2021-11-11T17:14:40-08:00February 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, according to a new study published in JAMA Internal Medicine and reported in today's New York Times. The new [...]

Psychopharmacology Bulletin, Volume 47, Number 1, 2017 On-Line Now

By |2021-11-11T17:14:49-08:00January 31st, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The latest edition of Psychopharmacology Bulletin is now available at: https://medworksmedia.com/product-category/psychopharmacology-bulletin/psychopharmacology-47-no-1/. Manuscripts include: Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study By Jin Shi Amon, Sarah B. Johnson, Rif S. El-Mallakh A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae By Badari Birur, Suresh Bada Math, Rachel E. Fargason [...]

Tailored Exercise Can Be a Boon to People With Parkinson’s Disease

By |2021-11-11T17:14:58-08:00January 24th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

In a surprise to the conservative treatments by neurologists, tailored exercise treatment programs are being developed by physical therapists to specifically counter the unique movement impairments associated with Parkinson’s by training patients to make big strong movements that incorporate the principles of tai chi and boxing. Treatments can, as well, [...]

Taking a Chapter from Depression Treatment, Parkinson’s Therapy Gets Fresh Look From Device Makers

By |2021-11-11T17:15:08-08:00January 9th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Deep brain stimulation, an established therapy that modifies the brain's circuitry to treat symptoms of depression, Parkinson's disease and other movement disorders, is attracting fresh attention from medical-device makers who believe it is underused. St. Jude Medical Inc. recently introduced a new DBS system in the U.S., and Boston Scientific [...]

A Psychiatrist’s Quest to Understand PTSD: MDMA in the MIX

By |2021-11-11T17:15:19-08:00January 7th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Charles Marmar, a 71-year-old psychiatrist in New York, has spent his career studying post traumatic stress disorder, which has symptoms such as sleep disruption and vivid flashbacks of the traumatic experience. PTSD is often associated with war: Between 11% and 20% of veterans who served in Iraq and Afghanistan have [...]

Albuminuria Linked to Increased Risk for Dementia, Cognitive Impairment

By |2021-11-11T17:15:31-08:00December 21st, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Although past research has shown a link between renal dysfunction and cognitive impairment, a new systematic review shows that the presence of albuminuria specifically is also associated with an increased risk of developing cognitive impairment. The meta-analysis of 22 studies, each with at least 100 participants, was carried out to [...]

FDA to Pull Black-Box Warning on Chantix for Psychotic Side Effects

By |2021-11-11T17:15:39-08:00December 20th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Seven years after safety concerns altered the trajectory of Pfizer’s stop-smoking med Chantix, the FDA has pulled its black-box warning from the drug’s label, according to a well known online pharmaceutical news site, FiercePharma. FDA officials removed the warning after weighing data from the EAGLES postmarketing study showing that Chantix [...]

Go to Top